Genetic variation continues to occur in well-controlled HIV-1-infected patients
W. Dampier, M.R. Nonnemacher, J. Chang Mell and 9 more
Journal of Virus Eradication · 2015
doi:10.1016/s2055-6640(20)31349-2 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Background: HIV-1 viral persistence in light of long-term HAART is a major hurdle to a cure.Genomic editing techniques, such as the CRISPR/Cas9 system, hold the promise to permanently excise integrated virus from a host cell.Targets are defined by a 20-25 nucleotide guide RNA (gRNA) molecule complementary to the desired genomic region.However, due to the rapid mutation rate intrinsic to HIV replication, the virus in patients exists as a collection of distinct genomic variants, termed quasispecies.Presented here is a methodology for designing gRNA sequences which will cleave a patient's HIV quasispecies.Methods: PBMC genomic DNA was isolated from patients in the Drexel Medicine CNS AIDS Research and Eradication Study (CARES) Cohort and the long terminal repeat (LTR) of the HIV-1 quasispecies was sampled using Illumina Next Generation Sequencing (NGS).gRNAs were designed using a known positional binding profile to optimally target the quasispecies present in the sample.Using the entire collection of sequences from the CARES cohort, a package of three gRNAs (CARES-3) were designed.Results: The CARES-3 package alone could cleave 70% of the observed quasispecies in the cohort which accounts for >90% of the observable integrated virus of from any patient examined to date.Supplementing this with a package of personalized gRNAs of less than three additional sequences allowed us to target all patients to below our level of detection.Examining longitudinal samples collected over a five year period suggests that the personalized gRNAs will lose their effectiveness if treatment is delayed more than 6 months.Conclusions: Utilizing NGS sampling techniques and computational gRNA design, a package of less than six gRNAs can be developed which will cleave all observable quasispecies within the PBMC compartment.This work presents a step towards understanding the complex task of using excision therapy to target HIV-1 quasispecies in the infected human population.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.